Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for ENvue Medical (FEED) over the last 4 years, with Q3 2025 value amounting to $858434.0.

  • ENvue Medical's Shares Outstanding (Diluted Average) rose 20623.58% to $858434.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $858434.0, marking a year-over-year increase of 20623.58%. This contributed to the annual value of $269848.0 for FY2024, which is 6960.37% up from last year.
  • As of Q3 2025, ENvue Medical's Shares Outstanding (Diluted Average) stood at $858434.0, which was up 20623.58% from $484566.0 recorded in Q2 2025.
  • ENvue Medical's 5-year Shares Outstanding (Diluted Average) high stood at $1.7 million for Q3 2023, and its period low was $25312.0 during Q2 2024.
  • Moreover, its 4-year median value for Shares Outstanding (Diluted Average) was $742292.0 (2025), whereas its average is $871818.2.
  • Per our database at Business Quant, ENvue Medical's Shares Outstanding (Diluted Average) plummeted by 9847.73% in 2024 and then skyrocketed by 181437.26% in 2025.
  • Over the past 4 years, ENvue Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $1.4 million in 2022, then crashed by 88.79% to $159105.0 in 2023, then surged by 69.6% to $269848.0 in 2024, then surged by 218.12% to $858434.0 in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $858434.0 for Q3 2025, versus $484566.0 for Q2 2025 and $626150.0 for Q1 2025.